2 hours ago
2
David Moadel
Wed, April 15, 2026 astatine 10:23 AM CDT 4 min read
-
Zoetis (ZTS) received a Buy standing and $145 terms people from Citi arsenic apical prime successful carnal health, citing the humanization of pets driving symptom absorption spending successful a marketplace wherever 40% of dogs and cats endure from osteoarthritis.
-
Citi initiated sum crossed the carnal wellness assemblage with assurance that favored humanization is simply a durable taste inclination that volition prolong spending connected veterinary medicines and vaccinations, particularly for caller long-acting symptom products Lenivia and Portela launching successful 2026.
-
The expert who called NVIDIA successful 2010 conscionable named his apical 10 AI stocks. Get them present FREE.
One of Wall Street's apical firms conscionable gave a thumbs-up to Zoetis (NYSE:ZTS) stock. Citi initiated sum with a Buy standing and a $145 terms target, naming it the firm's apical prime successful the carnal wellness group. The thesis is straightforward: radical dainty their animals similar family.
The initiation is portion of a broader assemblage launch. Citi launched sum of the carnal wellness and dental sectors with a "cautiously optimistic" view, besides initiating connected Elanco Animal Health (NYSE:ELAN), IDEXX Laboratories (NASDAQ:IDXX), and Phibro Animal Health (NASDAQ:PAHC) simultaneously. Among the group, Zoetis stands retired arsenic Citi's clearest condemnation play.
| ZTS | Zoetis | Citi | Initiation / Top Pick | N/A | Buy | N/A | $145 |
Citi's thesis rests connected the "humanization" of pets. The steadfast says the humanization favored inclination is existent and should thrust much spending, a presumption supported by information showing astir 40% of dogs of immoderate property oregon size whitethorn beryllium affected by OA symptom and up to 40% of each cats person objective signs of OA. That's a monolithic addressable marketplace for Zoetis's symptom absorption portfolio.
READ: The expert who called NVIDIA successful 2010 just named his apical 10 AI stocks
Citi besides opened an "upside 90-day catalyst watch" connected Zoetis, saying Solensia volition instrumentality to maturation successful fiscal 2026. That's a circumstantial near-term awesome worthy watching, particularly since U.S. mAb products including Librela and Solensia declined successful Q4 2025.
Zoetis is the world's largest shaper of medicine and vaccinations for pets and livestock, with FY2025 gross of $9.467 cardinal and a marketplace headdress of astir $51 billion. Its companion carnal conception generated $1.601 cardinal successful Q4 2025 revenue, increasing 2% twelvemonth implicit year.
The pipeline strengthens the story. Zoetis received regulatory approvals for long-acting OA symptom products Lenivia and Portela successful Canada and the EU, with commercialized launches expected successful 2026. CEO Kristin Peck asserted, "Advancing our innovative pipeline is cardinal to our strategy, and we achieved cardinal milestones successful 2025, including the archetypal regulatory approvals for long-acting OA symptom products Lenivia and Portela."
English (CA) · 
English (US) · 
Spanish (MX) ·